- Home
- ICLR vs ALLE Comparison
ICLR vs ALLE Comparison
Compare ICLR & ALLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- ALLE
- Stock Information
- Founded
- ICLR 1990
- ALLE 2013
- Country
- ICLR Ireland
- ALLE Ireland
- Employees
- ICLR N/A
- ALLE N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- ALLE Diversified Commercial Services
- Sector
- ICLR Health Care
- ALLE Consumer Discretionary
- Exchange
- ICLR Nasdaq
- ALLE Nasdaq
- Market Cap
- ICLR 11.5B
- ALLE 10.6B
- IPO Year
- ICLR 1998
- ALLE N/A
- Fundamental
- Price
- ICLR $133.96
- ALLE $141.86
- Analyst Decision
- ICLR Buy
- ALLE Hold
- Analyst Count
- ICLR 12
- ALLE 5
- Target Price
- ICLR $206.64
- ALLE $140.40
- AVG Volume (30 Days)
- ICLR 2.1M
- ALLE 940.9K
- Earning Date
- ICLR 04-30-2025
- ALLE 04-24-2025
- Dividend Yield
- ICLR N/A
- ALLE 1.44%
- EPS Growth
- ICLR 11.53
- ALLE 16.19
- EPS
- ICLR 9.19
- ALLE 7.12
- Revenue
- ICLR $8,192,621,999.00
- ALLE $3,820,200,000.00
- Revenue This Year
- ICLR $1.63
- ALLE $4.34
- Revenue Next Year
- ICLR $4.82
- ALLE $4.34
- P/E Ratio
- ICLR $15.07
- ALLE $19.90
- Revenue Growth
- ICLR N/A
- ALLE 5.48
- 52 Week Low
- ICLR $133.28
- ALLE $113.27
- 52 Week High
- ICLR $347.72
- ALLE $156.10
- Technical
- Relative Strength Index (RSI)
- ICLR 33.96
- ALLE 66.13
- Support Level
- ICLR $135.00
- ALLE $139.11
- Resistance Level
- ICLR $141.96
- ALLE $142.53
- Average True Range (ATR)
- ICLR 6.69
- ALLE 2.62
- MACD
- ICLR 0.43
- ALLE 0.72
- Stochastic Oscillator
- ICLR 3.63
- ALLE 96.35
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.